Aberrant methylation patterns of the Rassf1a gene in rat lung adenocarcinomas induced by N-nitrosobis(2-hydroxypropyl)amine

Molecular Carcinogenesis

Volumn 45, Issue 2, 2006, Pages 112-117

  Shimizu, Kyoko ^a   Kato, Ayumi ^a   Shigemura, Mayumi ^a   Fujii, Hiromasa ^b   Honoki, Kenya ^b   Tsujiuchi, Toshifumi ^a,c  

^a KINKI UNIVERSITY   (Japan)

^b NARA MEDICAL UNIVERSITY   (Japan)

^c NONE   (Japan)

Author keywords

DNA methylation; Lung adenocarcinoma; Nitrosamine; Rassf1a; Rat

Indexed keywords

BIS(2 HYDROXYPROPYL)NITROSAMINE; BISULFITE; DRINKING WATER; GENOMIC DNA; RAS ASSOCIATION DOMAIN FAMILY PROTEIN 1A; RNA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER MODEL; CONTROLLED STUDY; DNA EXTRACTION; DNA METHYLATION; EXON; GENE; GENE EXPRESSION; GENE INACTIVATION; GENE SEQUENCE; LUNG ADENOCARCINOMA; LUNG CARCINOGENESIS; MALE; MUTATIONAL ANALYSIS; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RASSF1A GENE; RAT; RAT STRAIN; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA EXTRACTION; SEQUENCE ANALYSIS; SINGLE STRAND CONFORMATION POLYMORPHISM;

ADENOCARCINOMA; ANIMALS; BASE SEQUENCE; DNA METHYLATION; LUNG; LUNG NEOPLASMS; MALE; MOLECULAR SEQUENCE DATA; MUTATION; NITROSAMINES; RATS; REFERENCE VALUES; TUMOR SUPPRESSOR PROTEINS;

ANIMALIA; RATTUS NORVEGICUS;

EID: 32044452007     PISSN: 08991987     EISSN: 10982744     Source Type: Journal    
DOI: 10.1002/mc.20173     Document Type: Article

References (35)

1. Kok H, Osinga J, Carrit B, et al. Deletion of a DNA sequence at the chromosomal region 3p21 in all major types of lung cancer. Nature (London) 1987;330:578-581.
2. Naylor SL, Johnson BE, Minna JD, Sakaguchi AY. Loss of heterozygosity of chromosome 3p markers in small-cell lung cancer. Nature(London) 1987;329:451-454.
3. Brauch H, Johnson B, Hovis J, et al. Molecular analysis of the short arm of chromosome 3 in small-cell and non-small-cell carcinoma of the lung. N Engl J Med 1987;317:1109-1113.
4. Yokota J, Wada M, Shimosato Y, Terada M, Sugimura T. Loss of heterozygosity on chromosome 3, 13, 17 in small cell carcinoma and chromosome 3 in adenocarcinoma of the lung. Proc Natl Acad Sci USA 1987;84:9252-9256.
5. Kok K, Naylor SL, Buys CH. Deletions of the short arm of chromosome 3 in solid tumors and the search for suppressor genes. Adv Cancer Res 1997;71:27-92.
6. Zabarovsky ER, Lerman MI, Minna JD. Tumor suppressor genes on chromosome 3p involved in the pathogenesis of lung and other cancers. Oncogene 2002;21:6915-6935.
7. Dammann R, Li C, Yoon JH, Chin PL, Bates S, Pfeifer GP. Epigenetic inactivation of a RAS association domain family protein from the lung tumour suppressor locus 3p21.3. Nature Genet 2000;25:315-319.
8. Kim ST, Lim DS, Canman CE, Kastan MB. Substrate specificities and identification of putative substrates of ATM kinase family members. J Biol Chem 1999;274: 37538-37543.
9. Vos MD, Ellis CA, Bell A, Birrer MJ, Clark GJ. Ras uses the novel tumor suppressor RASSF1 as an effector to mediate apoptosis. J Biol Chem 2000;275:35669-35672.
10. Dallol A, Agathanggelou A, Fenton SL, et al. RASSF1A interacts with microtubule-associated proteins and modulates microtubule dynamics. Cancer Res 2004;64: 4112-4116.
11. Tomizawa Y, Kohno T, Kondo H, et al. Clinicopathological significance of epigenetic inactivation of RASSF1A at 3p21.3 in stage I lung adenocarcinoma. Clin Cancer Res 2002;8: 2362-2368.
12. Burbee DG, Forgacs E, Zochbauer-Muller S, et al. Epigenetic inactivation of RASSF1A in lung and breast cancers and malignant phenotype suppression. J Natl Cancer Inst 2001; 93:691-699.
13. Dammann R, Takahashi T, Pfeifer GP. The CpG island of the novel tumor suppressor gene Rassf1a is intensely methylated in primary small cell lung carcinomas. Oncogene 2001;20: 3563-3567.
14. Endoh H, Yatabe Y, Shimizu S, et al. Rassf1a gene inactivation in non-small cell lung cancer and its clinical implication. Int J Cancer 2003;106:45-51.
15. Konishi Y, Denda A, Kondo H, Takahashi S. Lung carcinomas induced by oral administration of N-bis(2-hydroxypropyl)nitrosamine in rats. Jpn J Cancer Res 1976;67:773-780.
16. Konishi Y, Kondoh H, Denda A, Takahashi S, Inui S. Lung carcinomas induced by oral administration of N-bis (2-hydroxypropyl)nitrosamine in rats. In: Severi I, editor. Tumors of early life in man and animals. Perugia Quadrennaial International Conference of Cancer. Perugia: Division of Cancer Research, Perugia University; 1978, pp 637-649.
17. Kitada H, Tsutsumi M, Tsujiuchi T, et al. Frequent mutations of Ki-ras but no mutations of Ha-ras and p53 in lung lesions induced N-nitrosobis(2- hydroxypropyl) amine by in rat. Mol Carcinog 1996;115:276-283.
18. Tsujiuchi T, Tsutsumi M, Sasaki Y, Murata N, Konishi Y. Mutations of adenomatous polyposis coli and β-catenin genes during progression of lung tumors induced by N-nitrosobis(2-hydroxypropyl) amine by in rat. Cancer Res 2000;60:6611-6616.
19. Tsujiuchi T, Sasaki Y, Tsutsumi M, Konishi Y. Alterations of the M6p/Igf2 receptor gene in lung adenocarcinomas induced by N-nitrosobis(2-hydroxypropyl) amine in rat. Mol Carcinog 2003;36:32-37.
20. Tsujiuchi T, Sasaki Y, Tsutsumi M, Konishi Y. Mutations and reduced expression of the transforming growth factor-βreceptor II gene in rat lung adenocarcinomas induced N-nitrosobis(2-hydroxypropyl) amine. Jpn J Cancer Res 2000; 91:1090-1095.
21. Tsujiuchi T, Sasaki Y, Tsutsumi M, Konishi Y. Mutations of the smad2 and smad4 genes in lung adenocarcinomas induced N-nitrosobis(2-hydroxypropyl) amine in rats. Mol Carcinog 2000;29:87-91.
22. Shimizu K, Kato A, Hinotsume D, et al. Reduced expressions of Foxp1 and Rassf1a gene in lung adenocarcinomas induced N-nitrosobis(2-hydroxypropyl) amine in rats. Cancer Lett 2005 (in press).
23. Abe M, Okochi E, Kuramoto T, et al. Cloning of the 5′ upstream region of the rat p16 gene and its role in silencing. Jpn J Cancer Res 2002;249:75-86.
24. Honoki K, Tsujiucji T, Mori T, et al. Expression of the p16INK4a gene and methylation pattern of CpG sites in the promoter region in rat tumor cell lines. Mol Carcinog 2004; 39:10-14.
25. Wistubal I, Lam S, Behrens C, et al. Molecular damage in the bronchial epithelium of current and former smokers. J Natl Cancer Inst 1997;89:1366-1373.
26. Park IW, Wistuba II, Maitra A. Multiple clonal abnormalities in the bronchial epithelium of patient with lung cancer. J Natl Cancer Inst 1999;91:863-1868.
27. Wistuba I I, Behrens C, Virmani AK, et al. High resolution chromosome 3p allelotyping of human lung cancer and preneoplastic/preinvasive bronchial epithelium reveals multiple, discontinuous sites of 3p allele loss and three regions of frequent breakpoints. Cancer Res 2000;60:1949-1960.
28. Hecht SS. Tabacco smoke carcinogens and lung cancer. J Natl Cancer Inst 1999;91:1194-1210.
29. Sozzi G, Veronese ML, Negrini M, et al. The FHIT gene at 3p14.2 is abnormal in lung cancer. Cell 1996;85:17-26.
30. Sozzi G, Pastorino U, Moiraghi L, et al. Loss of FHIT function in lung cancer and preinvasive bronchial lesions. Cancer Res 1998;58:5032-5037.
31. Tomizawa Y, Nakajima Y, Kohno T, et al. Clinicopathological significance of Fhit protein expression in stage I non-small cell lung carcinoma. Cancer Res 1998;58:5478-5783.
32. Tseng JE, Kemp BL, Khuri FR, et al. Loss of Fhit is frequent in stage I non-small cell lung cancer and in the lungs of chronic smokers. Cancer Res 1999;59:4789-4803.
33. Tsujiuchi T, Sasaki Y, Murata N, et al. FHIT alterations in lung adencarcinomas induced by N-nitrosobis (2-hydroxypropyl)amine in rats. Carcinogenesis 2001;22:2017-2022.
34. Sundaresan V, Chung G, Heppell-Parton A, et al. Homozygous deletions at 3p12 in breast and lung cancer. Oncogene 1998;17:1723-1729.
35. Tsujiuchi T, Sasaki Y, Oka Y, et al. Alterations of the Dutt1/Robol gene in lung adenocarcinomas induced by N-nitrosobis(2-hydroxypropyl)amine in rats. Mol Carcinog 2004;40:241-246.